Authors: Andreassen, OA Dedeoglu, A Ferrante, RJ Jenkins, BG Ferrante, KL Thomas, M Friedlich, A Browne, SE Schilling, G Borchelt, DR Hersch, SM Ross, CA Beal, MF

Citation: Oa. Andreassen et al., Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease, NEUROBIOL D, 8(3), 2001, pp. 479-491

Authors: Andreassen, OA Ferrante, RJ Huang, HM Dedeoglu, A Park, L Ferrante, KL Kwon, J Borchelt, DR Ross, CA Gibson, GE Beal, MF

Citation: Oa. Andreassen et al., Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease, ANN NEUROL, 50(1), 2001, pp. 112-117

Authors: Andreassen, OA Jenkins, BG Dedeoglu, A Ferrante, KL Bogdanov, MB Kaddurah-Daouk, R Beal, MF

Citation: Oa. Andreassen et al., Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation, J NEUROCHEM, 77(2), 2001, pp. 383-390

Authors: Andreassen, OA Dedeoglu, A Friedlich, A Ferrante, KL Hughes, D Szabo, C Beal, MF

Citation: Oa. Andreassen et al., Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice, EXP NEUROL, 168(2), 2001, pp. 419-424